You are here

t cell therapy

Novartis taps Vyriad’s viral vectors to develop in vivo T cell editing

Fierce Biotech

Wed, 11/20/24 - 08:44 pm

After scoring a first for an off-the-shelf T cell therapy, can Atara maintain momentum?

Pharma Voice

Tue, 10/1/24 - 09:52 am

Atara Biotherapeutics

Gilead again backs AlloVir's T cell therapy in $127M direct offering

Endpoints

Wed, 07/27/22 - 10:53 am

Gilead Sciences

TCR² releases early data from some PhI patients, sparking optimism from analysts

Endpoints

Mon, 07/27/20 - 11:03 am

TCR2 Therapeutics

clinical trials

After setback, Adaptimmune revamps T cell study

BioPharma Dive

Thu, 10/13/16 - 10:53 am

Bellicum Therapy Reduces Risk from Mismatched Stem Cell Transplants

TheStreet.com

Sun, 12/6/15 - 10:02 am

Bluebird, Celgene See Promise in T Cell Therapy for Multiple Myeloma

TheStreet.com

Sat, 12/5/15 - 12:37 pm

Multiple Myeloma